Jim Simons's position in Editas Medicine is currently worth $2.85 Million. That's 0.00% of their equity portfolio (1629th largest holding). The first Editas Medicine trade was made in Q2 2016. Since then Jim Simons bought shares ten more times and sold shares on ten occasions. The investor's estimated purchase price is $4.45 Million, resulting in a loss of 36%.